Amedisys Total Assets from 2010 to 2024

AMED Stock

USD 90.64 0.48 0.53%

Amedisys' Total Assets are increasing over the years with slightly volatile fluctuation. Overall, Total Assets are expected to go to about 2.2 B this year. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

1993-12-31

Previous Quarter

2.1 B

Current Value

2.1 B

Quarterly Volatility

649.3 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Amedisys financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amedisys' main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.6 M, Interest Expense of 32.8 M or Selling General Administrative of 333.3 M, as well as many indicators such as Price To Sales Ratio of 0.86, Dividend Yield of 3.0E-4 or PTB Ratio of 2.57. Amedisys financial statements analysis is a perfect complement when working with Amedisys Valuation or Volatility modules.

Check out the analysis of Amedisys Correlation against competitors.

For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.

Latest Amedisys' Total Assets Growth Pattern

Below is the plot of the Total Assets of Amedisys over the last few years. Total assets refers to the total amount of Amedisys assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Amedisys books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Amedisys' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amedisys' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 2.06 B

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Amedisys Total Assets Regression Statistics

	Arithmetic Mean	1,121,703,100
	Geometric Mean	746,487,721
	Coefficient Of Variation	57.80
	Mean Deviation	554,171,453
	Median	813,482,000
	Standard Deviation	648,387,829
	Sample Variance	420406.8T
	Range	2.2B
	R-Value	0.91
	Mean Square Error	78581.1T
	R-Squared	0.83
	Slope	131,802,623
	Total Sum of Squares	5885694.9T

Amedisys Total Assets History

	2024	2.2 B
	2023	2.1 B
	2022	2 B
	2021	1.9 B
	2020	1.6 B
	2019	1.3 B
	2018	717.1 M

Other Fundumenentals of Amedisys

Intangibles To Total Assets

Amedisys Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Current Deferred Revenue	Common Stock	Long Term Debt	Treasury Stock	Property Plant Equipment	Good Will	Intangible Assets	Short Term Investments	Net Tangible Assets	Total Permanent Equity	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	0.91	0.95	0.6	0.95	0.99	0.95	0.91	0.37	0.53	0.94	-0.92	-0.24	0.98	0.89	0.77	-0.81	0.29	0.88	0.85	0.4	0.72	0.8	0.91	-0.64	0.81
Total Stockholder Equity	0.99		0.87	0.93	0.64	0.97	0.97	0.95	0.9	0.38	0.58	0.92	-0.9	-0.24	0.97	0.88	0.75	-0.75	0.27	0.84	0.85	0.35	0.71	0.79	0.88	-0.62	0.79
Net Debt	0.91	0.87		0.91	0.55	0.8	0.92	0.76	0.84	0.49	0.37	0.99	-0.88	-0.18	0.93	0.91	0.73	-0.88	0.34	0.91	0.76	0.5	0.77	0.65	0.95	-0.56	0.67
Retained Earnings	0.95	0.93	0.91		0.47	0.87	0.94	0.85	0.91	0.43	0.29	0.94	-0.95	-0.37	0.98	0.88	0.86	-0.92	0.49	0.94	0.81	0.63	0.78	0.81	0.95	-0.66	0.84
Accounts Payable	0.6	0.64	0.55	0.47		0.69	0.58	0.56	0.37	0.43	0.78	0.52	-0.59	-0.05	0.57	0.72	0.4	-0.33	0.07	0.26	0.69	0.06	0.31	0.08	0.51	-0.6	0.17
Net Receivables	0.95	0.97	0.8	0.87	0.69		0.92	0.97	0.83	0.31	0.63	0.84	-0.88	-0.29	0.91	0.84	0.75	-0.67	0.34	0.74	0.86	0.33	0.66	0.73	0.8	-0.65	0.74
Total Liab	0.99	0.97	0.92	0.94	0.58	0.92		0.93	0.9	0.33	0.49	0.95	-0.91	-0.23	0.98	0.89	0.78	-0.84	0.31	0.89	0.84	0.44	0.69	0.79	0.92	-0.67	0.81
Total Current Assets	0.95	0.95	0.76	0.85	0.56	0.97	0.93		0.85	0.22	0.57	0.82	-0.83	-0.3	0.9	0.78	0.72	-0.66	0.29	0.76	0.82	0.3	0.63	0.82	0.78	-0.58	0.81
Short Term Debt	0.91	0.9	0.84	0.91	0.37	0.83	0.9	0.85		0.42	0.29	0.87	-0.79	-0.2	0.89	0.76	0.68	-0.75	0.33	0.88	0.68	0.39	0.72	0.86	0.86	-0.42	0.85
Current Deferred Revenue	0.37	0.38	0.49	0.43	0.43	0.31	0.33	0.22	0.42		0.16	0.44	-0.43	-0.22	0.41	0.43	0.25	-0.39	0.17	0.35	0.35	0.22	0.49	0.1	0.5	-0.08	0.08
Common Stock	0.53	0.58	0.37	0.29	0.78	0.63	0.49	0.57	0.29	0.16		0.39	-0.42	0.12	0.42	0.57	0.23	-0.08	-0.25	0.14	0.67	-0.26	0.34	0.17	0.36	-0.36	0.28
Long Term Debt	0.94	0.92	0.99	0.94	0.52	0.84	0.95	0.82	0.87	0.44	0.39		-0.89	-0.23	0.96	0.91	0.73	-0.88	0.33	0.95	0.79	0.47	0.79	0.74	0.96	-0.54	0.74
Treasury Stock	-0.92	-0.9	-0.88	-0.95	-0.59	-0.88	-0.91	-0.83	-0.79	-0.43	-0.42	-0.89		0.42	-0.96	-0.89	-0.93	0.89	-0.52	-0.85	-0.9	-0.68	-0.76	-0.68	-0.91	0.78	-0.74
Property Plant Equipment	-0.24	-0.24	-0.18	-0.37	-0.05	-0.29	-0.23	-0.3	-0.2	-0.22	0.12	-0.23	0.42		-0.34	-0.19	-0.54	0.45	-0.54	-0.35	-0.41	-0.61	-0.25	-0.37	-0.3	0.36	-0.37
Good Will	0.98	0.97	0.93	0.98	0.57	0.91	0.98	0.9	0.89	0.41	0.42	0.96	-0.96	-0.34		0.91	0.83	-0.89	0.4	0.92	0.86	0.54	0.75	0.79	0.95	-0.68	0.81
Intangible Assets	0.89	0.88	0.91	0.88	0.72	0.84	0.89	0.78	0.76	0.43	0.57	0.91	-0.89	-0.19	0.91		0.71	-0.82	0.34	0.81	0.9	0.43	0.79	0.58	0.94	-0.63	0.68
Short Term Investments	0.77	0.75	0.73	0.86	0.4	0.75	0.78	0.72	0.68	0.25	0.23	0.73	-0.93	-0.54	0.83	0.71		-0.84	0.65	0.75	0.78	0.84	0.63	0.62	0.76	-0.83	0.7
Net Tangible Assets	-0.81	-0.75	-0.88	-0.92	-0.33	-0.67	-0.84	-0.66	-0.75	-0.39	-0.08	-0.88	0.89	0.45	-0.89	-0.82	-0.84		-0.57	-0.93	-0.73	-0.78	-0.71	-0.69	-0.93	0.66	-0.73
Total Permanent Equity	0.29	0.27	0.34	0.49	0.07	0.34	0.31	0.29	0.33	0.17	-0.25	0.33	-0.52	-0.54	0.4	0.34	0.65	-0.57		0.44	0.37	0.81	0.33	0.32	0.41	-0.5	0.33
Long Term Debt Total	0.88	0.84	0.91	0.94	0.26	0.74	0.89	0.76	0.88	0.35	0.14	0.95	-0.85	-0.35	0.92	0.81	0.75	-0.93	0.44		0.71	0.59	0.79	0.85	0.94	-0.47	0.85
Capital Surpluse	0.85	0.85	0.76	0.81	0.69	0.86	0.84	0.82	0.68	0.35	0.67	0.79	-0.9	-0.41	0.86	0.9	0.78	-0.73	0.37	0.71		0.46	0.75	0.62	0.85	-0.71	0.73
Deferred Long Term Liab	0.4	0.35	0.5	0.63	0.06	0.33	0.44	0.3	0.39	0.22	-0.26	0.47	-0.68	-0.61	0.54	0.43	0.84	-0.78	0.81	0.59	0.46		0.44	0.37	0.55	-0.66	0.45
Long Term Investments	0.72	0.71	0.77	0.78	0.31	0.66	0.69	0.63	0.72	0.49	0.34	0.79	-0.76	-0.25	0.75	0.79	0.63	-0.71	0.33	0.79	0.75	0.44		0.66	0.82	-0.25	0.71
Short Long Term Debt	0.8	0.79	0.65	0.81	0.08	0.73	0.79	0.82	0.86	0.1	0.17	0.74	-0.68	-0.37	0.79	0.58	0.62	-0.69	0.32	0.85	0.62	0.37	0.66		0.74	-0.32	0.95
Net Invested Capital	0.91	0.88	0.95	0.95	0.51	0.8	0.92	0.78	0.86	0.5	0.36	0.96	-0.91	-0.3	0.95	0.94	0.76	-0.93	0.41	0.94	0.85	0.55	0.82	0.74		-0.58	0.79
Net Working Capital	-0.64	-0.62	-0.56	-0.66	-0.6	-0.65	-0.67	-0.58	-0.42	-0.08	-0.36	-0.54	0.78	0.36	-0.68	-0.63	-0.83	0.66	-0.5	-0.47	-0.71	-0.66	-0.25	-0.32	-0.58		-0.45
Capital Stock	0.81	0.79	0.67	0.84	0.17	0.74	0.81	0.81	0.85	0.08	0.28	0.74	-0.74	-0.37	0.81	0.68	0.7	-0.73	0.33	0.85	0.73	0.45	0.71	0.95	0.79	-0.45

Click cells to compare fundamentals

About Amedisys Financial Statements

Amedisys stakeholders use historical fundamental indicators, such as Amedisys' Total Assets, to determine how well the company is positioned to perform in the future. Although Amedisys investors may analyze each financial statement separately, they are all interrelated. For example, changes in Amedisys' assets and liabilities are reflected in the revenues and expenses on Amedisys' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Amedisys. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	2.1 B	2.2 B
Intangibles To Total Assets	0.65	0.38

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether Amedisys is a strong investment it is important to analyze Amedisys' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Amedisys' future performance. For an informed investment choice regarding Amedisys Stock, refer to the following important reports:

How To Invest In Amedisys

Details

Is Amedisys Stock a good investment?

Details

What is Amedisys' Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Amedisys Correlation against competitors.

For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.

You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amedisys. If investors know Amedisys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amedisys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.35)

Earnings Share

2.52

Revenue Per Share

71.004

Quarterly Revenue Growth

0.057

Return On Assets

0.0627

The market value of Amedisys is measured differently than its book value, which is the value of Amedisys that is recorded on the company's balance sheet. Investors also form their own opinion of Amedisys' value that differs from its market value or its book value, called intrinsic value, which is Amedisys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amedisys' market value can be influenced by many factors that don't directly affect Amedisys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Amedisys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amedisys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amedisys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Amedisys Total Assets from 2010 to 2024

Latest Amedisys' Total Assets Growth Pattern

Amedisys Total Assets Regression Statistics

Amedisys Total Assets History

Other Fundumenentals of Amedisys

Amedisys Total Assets component correlations

About Amedisys Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY